3D Med, Alphamab Get First SubQ Immuno-Oncology Approval, In China
Home-Grown Partnership Pays Dividends
A landmark approval and domestic tie-up in China mark the fast innovation that is shaping the country’s health sector.
A landmark approval and domestic tie-up in China mark the fast innovation that is shaping the country’s health sector.